Free Trial

Enzo Biochem (ENZ) News Today

Enzo Biochem logo
$0.66 -0.01 (-1.35%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com
NYSE notifies Enzo Biochem not in compliance with certain requirements
Enzo Biochem Faces NYSE Compliance Challenges
Enzo Biochem, Inc. stock logo
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)
StockNews.com started coverage on shares of Enzo Biochem in a report on Tuesday. They set a "hold" rating on the stock.
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Announces Quarterly Earnings Results
Enzo Biochem (NYSE:ENZ - Get Free Report) issued its quarterly earnings data on Monday. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.
Enzo Biochem, Inc. stock logo
StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)
StockNews.com began coverage on shares of Enzo Biochem in a report on Monday. They issued a "hold" rating for the company.
Enzo Biochem, Inc. stock logo
Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Down 9.3% in November
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large drop in short interest in November. As of November 15th, there was short interest totalling 433,000 shares, a drop of 9.3% from the October 31st total of 477,500 shares. Based on an average daily volume of 86,700 shares, the days-to-cover ratio is currently 5.0 days. Currently, 1.2% of the company's stock are sold short.
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Enzo Biochem in a research note on Sunday. They set a "hold" rating for the company.
Enzo Biochem Appoints Jon Couchman to Board
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Enzo Biochem in a research note on Saturday. They issued a "hold" rating on the stock.
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com
StockNews.com began coverage on Enzo Biochem in a research note on Friday. They set a "hold" rating for the company.
Enzo Biochem (NYSE:ENZ) Stock, Option Chain
Enzo Biochem Reports Revenue Growth Despite Losses
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Stock Price Passes Above 200 Day Moving Average - Should You Sell?
Enzo Biochem (NYSE:ENZ) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com
StockNews.com started coverage on Enzo Biochem in a research report on Tuesday. They issued a "hold" rating on the stock.
Enzo Biochem, Inc. stock logo
Enzo Biochem, Inc. (NYSE:ENZ) Sees Significant Increase in Short Interest
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Approximately 1.4% of the shares of the stock are short sold. Based on an average daily volume of 74,600 shares, the days-to-cover ratio is currently 6.9 days.
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Shares Pass Above 200-Day Moving Average of $1.13
Enzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.13
Enzo Biochem Inc (EZB.DU)
Enzo Biochem, Inc. stock logo
Enzo Biochem (NYSE:ENZ) Share Price Crosses Above 200-Day Moving Average of $1.14
Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200-Day Moving Average of $1.14
Enzo Biochem, Inc. stock logo
Short Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 10.0%
Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 531,800 shares, a decline of 10.0% from the July 15th total of 591,200 shares. Based on an average trading volume of 119,600 shares, the short-interest ratio is presently 4.4 days. Currently, 1.5% of the shares of the stock are sold short.
ENZ Enzo Biochem, Inc.
Get Enzo Biochem News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter.

ENZ Media Mentions By Week

ENZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENZ
News Sentiment

0.20

0.44

Average
Medical
News Sentiment

ENZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENZ Articles
This Week

8

1

ENZ Articles
Average Week

Get Enzo Biochem News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ENZ) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners